The official kick-off meeting of PerSAIDs “Personalised medicine per SAIDs” project was held online on 21 June 2022. The coordinator presented the overall project, followed by presentations by the 6 partners to introduce their organizations and the next steps.
PerSAIDs is funded by the European ERAPerMED programme with 1,089,088 euros for 36 months, from May 2022 to April 2025. The project aims to develop novel approaches to improve SAIDs classification, diagnosis and prognosis, also leveraging machine learning algorithms, and includes 6 partners from Italy, Germany, Austria, Turkey and Spain.